StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI)
StockNews.com started coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note issued to investors on Monday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, HC Wainwright boosted their target price on shares of CASI Pharmaceuticals from $10.00 to $12.00 and gave the company a buy […]
More Stories
Sprout Social, Inc. (NASDAQ:SPT) Receives $45.46 Average PT from Brokerages
Sprout Social, Inc. (NASDAQ:SPT – Get Free Report) has been assigned a consensus recommendation of “Hold” from the fifteen research...
Converge Technology Solutions Corp. (TSE:CTS) Receives C$5.86 Average PT from Analysts
Shares of Converge Technology Solutions Corp. (TSE:CTS – Get Free Report) have earned an average recommendation of “Moderate Buy” from...
Wesdome Gold Mines Ltd. (TSE:WDO) Given Average Rating of “Moderate Buy” by Brokerages
Wesdome Gold Mines Ltd. (TSE:WDO – Get Free Report) has earned a consensus rating of “Moderate Buy” from the seven...
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Given Consensus Recommendation of “Buy” by Analysts
Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have received an average recommendation of “Buy” from the...
Volt Resources Limited (ASX:VRC) Insider Buys A$18,441.67 in Stock
Volt Resources Limited (ASX:VRC – Get Free Report) insider Dominic Virgara bought 6,147,222 shares of the stock in a transaction...
Patriot Lithium Limited (ASX:PAT) Insider Acquires A$48,000.00 in Stock
Patriot Lithium Limited (ASX:PAT – Get Free Report) insider Hugh Warner purchased 1,000,000 shares of the company’s stock in a...